| Virksomt stof | ATC-kode |
| Sabatolimab | L01FX19 |
| Sabatolimab | QL01FX19 |
| Saccharomyces boulardii | QA07FA02 |
| Saccharomyces boulardii | A07FA02 |
| Sacituzumab govitecan | L01FX17 |
| Sacituzumab govitecan | QL01FX17 |
| Sacrosidase | QA16AB06 |
| Sacrosidase | A16AB06 |
| Safinamid | N04BD03 |
| Safinamid | QN04BD03 |
| Salbutamol | QR03AC02 |
| Salbutamol | QR03CC02 |
| Salbutamol | R03AC02 |
| Salbutamol | R03CC02 |
| Salbutamol og andre midler mod obstruktiv lungesygdom | QR03AK04 |
| Salbutamol og beclometason | R03AK13 |
| Salbutamol og beclometason | QR03AK13 |
| Salbutamol og budesonid | QR03AK15 |
| Salbutamol og budesonid | R03AK15 |
| Salbutamol og ipratropiumbromid | R03AL02 |
| Salbutamol og ipratropiumbromid | QR03AL02 |
| Salbutamol og natriumcromoglicinsyre | R03AK04 |
| Salicylamid | QN02BA05 |
| Salicylamid | N02BA05 |
| Salicylamid, komb. excl. psykoleptika | QN02BA55 |
| Salicylamid, komb. med psykoleptika | QN02BA75 |
| Salicylamid, kombinationer excl. psykoleptika | N02BA55 |
| Salicylamid, kombinationer med psykoleptika | N02BA75 |
| Salicyloylsalcylsyre | N02BA06 |
| Salicyloylsalicylsyre | QN02BA06 |
| Salicylsyre | QS01BC08 |
| Salicylsyre | S01BC08 |
| Salicylsyre | D01AE12 |
| Salicylsyre | QD01AE12 |
| Salicylsyre og derivater | QN02BA |
| Salicylsyre-derivater | P02DA |
| Salicylsyre-derivater | N02BA |
| Salicylsyrepræparater | D02AF |
| Salicylsyre-præparater | QD02AF |
| Salinomycin | QP51BB01 |
| Salmeterol | QR03AC12 |
| Salmeterol | R03AC12 |
| Salmeterol og andre midler mod obstruktiv lungesygdom | QR03AK06 |
| Salmeterol og budesonid | QR03AK12 |
| Salmeterol og budesonid | R03AK12 |
| Salmeterol og fluticason | R03AK06 |
| Salmon pancreas disease (spd), proteinkodende plasmid | QI10AA02 |
| Salmon pancreas disease virus vaccine | QI10AA01 |
| Salmonella antiserum | QI02AM02 |
| Salmonella vaccine | QI02AE02 |
| Salmonella vaccine | QI09AB14 |
| Salmonella vaccine | QI09AE02 |
| Salmonella vaccine | QI01AB01 |
| Salmonella vaccine | QI01AE01 |
| Salmonella vaccine | QI01EE01 |
| Salmonella vaccine | QI02AB05 |
| Salmonella+ escherichia antiserum | QI02AM07 |
| Salmonella+pasteurella+escherichia antiserum | QI02AM06 |
| Saltopløsninger | QB05CB |
| Saltopløsninger | B05CB |
| Saltsyre | B05XA13 |
| Saltsyre | A09AB03 |
| Saltsyre | QB05XA13 |
| Saltsyre | QA09AB03 |
| Salve-forbindinger med antiinfektiva | QD09AA |
| Salvekompresser med antiinfektiva | D09AA |
| Samarium(153-sm)-ethylendiamintetramethylenphosphonsyre | V10BX02 |
| Samarium(153-sm)-hydroxyapatit kolloid | V10AX02 |
| Sampeginterferon beta-1a | L03AB17 |
| Sampeginterferon beta-1a | QL03AB17 |
| Sanseorganer | S |
| Sanseorganer | QS |
| Sapropterin | QA16AX07 |
| Sapropterin | A16AX07 |
| Saquinavir | J05AE01 |
| Saquinavir | QJ05AE01 |
| Sarafloxacin | QJ01MA98 |
| Sarecyclin | QJ01AA14 |
| Sarecyclin | J01AA14 |
| Sargramostim | L03AA09 |
| Sargramostim | QL03AA09 |
| Sarilumab | QL04AC14 |
| Sarilumab | L04AC14 |
| Sarmazenil | QV03AB91 |
| Sarolaner | QP53BE03 |
| Saruplase | B01AD08 |
| Saruplase | QB01AD08 |
| S-atenolol | QC07AB11 |
| S-atenolol | C07AB11 |
| Satralizumab | L04AC19 |
| Satralizumab | QL04AC19 |
| Satranidazol | P01AB08 |
| Satraplatin | QL01XA04 |
| Satraplatin | L01XA04 |
| Savolitinib | L01EP03 |
| Savpalmefrugt | G04CX02 |
| Savpalmefrugt | QG04CX02 |
| Saxagliptin | QA10BH03 |
| Saxagliptin | A10BH03 |
| Saxagliptin og dapagliflozin | A10BD21 |
| Saxagliptin og dapagliflozin | QA10BD21 |
| Scilla-glycosider | QC01AB |
| Scilla-glycosider | C01AB |
| Scleroserende midler til lokal injektion | C05BB |
| Scopolamin | A04AD01 |
| Scopolamin | N05CM05 |
| Scopolamin | QA04AD01 |
| Scopolamin | QN05CM05 |
| Scopolamin | QS01FA02 |
| Scopolamin | S01FA02 |
| Scopolamin, kombinationer | QA04AD51 |
| Scopolamin, kombinationspræparater | A04AD51 |
| Sebelipase alfa | A16AB14 |
| Sebelipase alfa | QA16AB14 |
| Sebetralstat | QB06AC08 |
| Sebetralstat | B06AC08 |
| Secale-alkaloider | G02AB |
| Secale-alkaloider | G02AB02 |
| Secale-alkaloider | QG02AB |
| Secale-alkaloider | QG02AB02 |
| Secale-alkaloider og oxytocin incl. derivater i kombination | G02AC |
| Secale-alkaloider og oxytocin incl.derivater,komb. | QG02AC |
| Secnidazol | P01AB07 |
| Secobarbital | N05CA06 |
| Secobarbital | QN05CA06 |
| Secobarbital | QN51AA02 |
| Secobarbital, komb. | QN51AA52 |
| Secretin | QV04CK01 |
| Secretin | V04CK01 |
| Secukinumab | QL04AC10 |
| Secukinumab | L04AC10 |
| Sekale-alkaloider | C04AE |
| Sekale-alkaloider | QC04AE |
| Sekundære og tertiære aminer | QC02BB |
| Sekundære og tertiære aminer | C02BB |
| Seladelpar | A05AX07 |
| Seladelpar | QA05AX07 |
| Selamectin | QP54AA05 |
| Selamectin, kombinationer | QP54AA55 |
| Selegilin | QN06AX90 |
| Selegilin | QN04BD01 |
| Selegilin | N04BD01 |
| Selektive 5ht(1)-receptor-agonister | N02CC |
| Selektive 5ht(1)-receptor-agonister | QN02CC |
| Selektive beta-2-adrenoceptor agonister | R03AC |
| Selektive beta-2-adrenoceptor agonister | R03CC |
| Selektive beta2-adrenoceptor agonister | QR03CC |
| Selektive beta-2-adrenoreceptor agonister | QR03AC |
| Selektive calciumantagonister m. direkte cardiel effekt | C08D |
| Selektive calciumantagonister m. direkte cardiel effekt | QC08D |
| Selektive calciumantagonister m. overv. vaskulær effekt | QC08C |
| Selektive calciumantagonister m. overv. vaskulær effekt | C08C |
| Selektive immunsuppressiva | L04AA |
| Selektive immunsuppressiva | QL04AA |
| Selektive serotonin re-optagelse inhibitorer | N06AB |
| Selektive serotonin reoptagelse-inhibitorer | QN06AB |
| Selektive østrogenreceptor-modulatorer | G03XC |
| Selektive østrogenreceptor-modulatorer | QG03XC |
| Selen | QA12CE |
| Selen | A12CE |
| Selen(75-se)-norcholesterol | V09XX03 |
| Selen(75-se)-tauroselcholinsyre | V09DX01 |
| Selen, kombinationer | QA12CE99 |
| Selenforbindelser | D11AC03 |
| Selen-forbindelser | QD11AC03 |
| Selensulfid | QD01AE13 |
| Selensulfid | D01AE13 |
| Selexipag | B01AC27 |
| Selexipag | QB01AC27 |
| Selinexor | QL01XX66 |
| Selinexor | L01XX66 |
| Selpercatinib | L01EX22 |
| Selpercatinib | QL01EX22 |
| Selumetinib | QL01EE04 |
| Selumetinib | L01EE04 |
| Semaglutid | A10BJ06 |
| Semaglutid | QA10BJ06 |
| Semustin | QL01AD03 |
| Semustin | L01AD03 |
| Senega | QR05CA06 |
| Senega | R05CA06 |
| Seniprutug | QL04AG17 |
| Seniprutug | L04AG17 |
| Senna-glycosider | QA06AB06 |
| Senna-glycosider, kombinationer | QA06AB56 |
| Sennes-glycosider | A06AB06 |
| Sennes-glycosider, kombinationspræparater | A06AB56 |
| Sensibilatorer anvendt til fotodynamisk/stråle- terapi | QL01XD |
| Sensibilatorer til fotodynamisk/stråle-terapi | L01XD |
| Sepiapterin | A16AX28 |
| Sepofarsen | QS01XA29 |
| Sepofarsen | S01XA29 |
| Sequifenadin | QR06AX32 |
| Sequifenadin | R06AX32 |
| Seratrodast | R03DX06 |
| Seratrodast | QR03DX06 |
| Serelaxin | C01DX21 |
| Serelaxin | QC01DX21 |
| Sermorelin | QH01AC04 |
| Sermorelin | H01AC04 |
| Sermorelin | QV04CD03 |
| Sermorelin | V04CD03 |
| Serotonin (5ht3) antagonister | A04AA |
| Serotonin (5ht3) antagonister | QA04AA |
| Serotonin antagonister | QC02KD |
| Serotonin-antagonister | C02KD |
| Serotonin-antagonister og diuretika | C02LN |
| Serotoninreceptor antagonister | A03AE |
| Serotoninreceptor antagonister | QA03AE |
| Serplulimab | QL01FF12 |
| Serplulimab | L01FF12 |
| Sertaconazol | D01AC14 |
| Sertaconazol | G01AF19 |
| Sertaconazol | QD01AC14 |
| Sertaconazol | QG01AF19 |
| Sertindol | N05AE03 |
| Sertindol | QN05AE03 |
| Sertralin | QN06AB06 |
| Sertralin | N06AB06 |
| Serumgonadotropin | G03GA03 |
| Serumgonadotropin | QG03GA03 |
| Setmelanotid | QA08AA12 |
| Setmelanotid | A08AA12 |
| Sevelamer | QV03AE02 |
| Sevelamer | V03AE02 |
| Sevofluran | QN01AB08 |
| Sevofluran | N01AB08 |
| Shope fibroma virus vaccine | QI08AD01 |
| Sibeprenlimab | L04AG18 |
| Sibutramin | A08AA10 |
| Sildenafil | G04BE03 |
| Sildenafil | QG04BE03 |
| Siliconepræparater | QD02AA |
| Siliconepræparater | D02AA |
| Siliconer | QA03AX13 |
| Siliconer, komb. | QA03AX63 |
| Silikoner | A03AX13 |
| Silodosin | G04CA04 |
| Silodosin | QG04CA04 |
| Siltuximab | L04AC11 |
| Siltuximab | QL04AC11 |
| Silymarin | A05BA03 |
| Silymarin | QA05BA03 |
| Simeprevir | QJ05AP05 |
| Simeprevir | J05AP05 |
| Simfibrat | C10AB06 |
| Simfibrat | QC10AB06 |
| Simvastatin | QC10AA01 |
| Simvastatin | C10AA01 |
| Simvastatin og acetylsalicylsyre | C10BX01 |
| Simvastatin og acetylsalicylsyre | QC10BX01 |
| Simvastatin og ezetimib | QC10BA02 |
| Simvastatin og ezetimib | C10BA02 |
| Simvastatin og fenofibrat | C10BA04 |
| Simvastatin og fenofibrat | QC10BA04 |
| Simvastatin, acetylsalicylsyre og ramipril | QC10BX04 |
| Simvastatin, acetylsalicylsyre og ramipril | C10BX04 |
| Sincalid | QV04CC03 |
| Sincalid | V04CC03 |
| Sinecatechins | D06BB12 |
| Sinecatechins | QD06BB12 |
| Sipavibart | J06BD09 |
| Siponimod | L04AE03 |
| Siponimod | QL04AE03 |
| Sipuleucel-t | L03AX17 |
| Sipuleucel-t | QL03AX17 |
| Sirolimus | QL01EG04 |
| Sirolimus | QC01EB90 |
| Sirolimus | L04AH01 |
| Sirolimus | L01EG04 |
| Sirolimus | QL04AH01 |
| Sirolimus | QS01XA23 |
| Sirolimus | S01XA23 |
| Sirukumab | QL04AC15 |
| Sirukumab | L04AC15 |
| Sisomicin | J01GB08 |
| Sisomicin | QJ01GB08 |
| Sitafloxacin | QJ01MA21 |
| Sitafloxacin | J01MA21 |
| Sitagliptin | A10BH01 |
| Sitagliptin | QA10BH01 |
| Sitagliptin og dapagliflozin | QA10BD29 |
| Sitagliptin og dapagliflozin | A10BD29 |
| Sitagliptin og ertugliflozin | A10BD24 |
| Sitagliptin og ertugliflozin | QA10BD24 |
| Sitagliptin og simvastatin | QA10BH51 |
| Sitagliptin og simvastatin | A10BH51 |
| Sitaxentan | C02KX03 |
| Sitaxentan | QC02KX03 |
| Sitimagen ceradenovec | QL01XL01 |
| Sitimagen ceradenovec | L01XL01 |
| Sitravatinib | L01EX26 |
| Sitravatinib | QL01EX26 |
| Skelet | QV09B |
| Skelet | V09B |
| Skimmel- og gærsvampe | V01AA04 |
| Skimmel- og gærsvampe | QV01AA04 |
| Skyllevæsker | QB05C |
| Skyllevæsker | B05C |
| Slangegift antiserum | J06AA03 |
| Slangegift antiserum | QI07AM04 |
| Smertepalliation (knogle-opsøgende midler) | V10B |
| Smitsom bronchitis virus vaccine | QI01AD07 |
| Smitsom bronchitis virus vaccine | QI01AA03 |
| Smitsom bronchitis virus+adenovirus vaccine | QI01AA14 |
| Smitsom bronchitis+newcastle disease virus vaccine | QI01AA10 |
| Smitsom bronchitis+newcastle disease+adenovirus+rhinotracheitis virus va | QI01AA18 |
| Smitsom bronchitis+newcastle disease+rhinotracheitis virus vaccine | QI01AA21 |
| Smitsom bronchitis+smitsom bursal disease virus vaccine | QI01AA15 |
| Smitsom bronchitis+smitsom bursal disease+newcastle disease virus vaccin | QI01AA08 |
| Smitsom bronchitis+smitsom bursal disease+newcastle disease+adenovirus v | QI01AA19 |
| Smitsom bronchitis+smitsom bursal disease+newcastle disease+reovirus vac | QI01AA16 |
| Smitsom bronchitis+smitsom bursal disease+newcastle disease+rhinotrachei | QI01AA06 |
| Smitsom bronchitis+smitsom bursal disease+newcastle disease+rhinotrachei | QI01AA07 |
| Smitsom bursal disease (gumboro disease)+herpes virus vaccine (marek's d | QI01AD15 |
| Smitsom bursal disease virus vaccine (gumboro disease) | QI01AD09 |
| Smitsom bursal disease virus vaccine (gumboro) | QI01AA01 |
| Smitsom bursal disease+newcastle disease virus vaccine | QI01AA11 |
| Smitsom bursal disease+reovirus vaccine | QI01AA22 |
| Smitsom laryngotracheitis virus vaccine | QI01AD08 |
| Sobrerol | QR05CB07 |
| Sobrerol | R05CB07 |
| Sofosbuvir | QJ05AP08 |
| Sofosbuvir | J05AP08 |
| Sofosbuvir og ledipasvir | J05AP51 |
| Sofosbuvir og ledipasvir | QJ05AP51 |
| Sofosbuvir og velpatasvir | QJ05AP55 |
| Sofosbuvir og velpatasvir | J05AP55 |
| Sofosbuvir, velpatasvir og voxilaprevir | J05AP56 |
| Sofosbuvir, velpatasvir og voxilaprevir | QJ05AP56 |
| Sofpironiumbromid | D11AA02 |
| Solifenacin | G04BD08 |
| Solifenacin | QG04BD08 |
| Solithromycin | QJ01FA16 |
| Solithromycin | J01FA16 |
| Solriamfetol | N06BA14 |
| Solriamfetol | QN06BA14 |
| Somapacitan | H01AC07 |
| Somapacitan | QH01AC07 |
| Somatorelin | QV04CD05 |
| Somatorelin | V04CD05 |
| Somatostatin | QH01CB01 |
| Somatostatin | H01CB01 |
| Somatostatin og analoger | H01CB |
| Somatostatin og analoger | QH01CB |
| Somatrem | QH01AC02 |
| Somatrem | H01AC02 |
| Somatrogon | H01AC08 |
| Somatrogon | QH01AC08 |
| Somatropin | QH01AC01 |
| Somatropin | H01AC01 |
| Somatropin og somatropin agonister | H01AC |
| Somatropin og somatropin agonister | QH01AC |
| Sonidegib | QL01XJ02 |
| Sonidegib | L01XJ02 |
| Sorafenib | L01EX02 |
| Sorafenib | QL01EX02 |
| Sorbitol | QB05CX02 |
| Sorbitol | QA06AD18 |
| Sorbitol | QA06AG07 |
| Sorbitol | B05CX02 |
| Sorbitol | A06AD18 |
| Sorbitol | A06AG07 |
| Sorbitol | V04CC01 |
| Sorbitol | QV04CC01 |
| Sotagliflozin | A10BK06 |
| Sotagliflozin | QA10BK06 |
| Sotalol | QC07AA07 |
| Sotalol | C07AA07 |
| Sotalol og acetylsalicylsyre | C07FX02 |
| Sotalol og acetylsalicylsyre | QC07FX02 |
| Sotalol og thiazider | C07BA07 |
| Sotatercept | C02KX06 |
| Sotatercept | QC02KX06 |
| Sotorasib | QL01XX73 |
| Sotorasib | L01XX73 |
| Sotrovimab | J06BD05 |
| Spagluminsyre | QS01GX03 |
| Spagluminsyre | R01AC05 |
| Spagluminsyre | S01GX03 |
| Spaglumsyre | QR01AC05 |
| Sparfloxacin | J01MA09 |
| Sparfloxacin | QJ01MA09 |
| Sparsentan | QC09XX01 |
| Sparsentan | C09XX01 |
| Spartein | C01BA04 |
| Spartein | QC01BA04 |
| Specifikke antireumatika | QM01C |
| Specifikke antirheumatiske midler | M01C |
| Specifikke immunoglobuliner | J06BB |
| Specifikke immunoglobuliner, komb. | J06BB30 |
| Spectinomycin | J01XX04 |
| Spectinomycin | QJ01XX04 |
| Spesolimab | L04AC22 |
| Spesolimab | QL04AC22 |
| Sphingosin 1-phosphat (s1p) receptormodulatorer | QL04AE |
| Sphingosin 1-phosphat (s1p) receptormodulatorer | L04AE |
| Spinetoram | QP53AX31 |
| Spinosad | QP53BX03 |
| Spiramycin | J01FA02 |
| Spiramycin | QJ01FA02 |
| Spiramycin | QJ51FA02 |
| Spiramycin og metronidazol | QJ01RA04 |
| Spiramycin og metronidazol | J01RA04 |
| Spiramycin, komb. med andre antibakterika | QJ51RF01 |
| Spirapril | QC09AA11 |
| Spirapril | C09AA11 |
| Spironolacton | C03DA01 |
| Spironolacton | QC03DA01 |
| Stafylokok + bacteriofag vaccine | QI07AV01 |
| Stafylokok vaccine | QI07AB02 |
| Stamceller fra navlestrengsblod | QB05AX04 |
| Stamceller fra navlestrengsblod | B05AX04 |
| Stannofluorid | A01AA04 |
| Stannofluorid | QA01AA04 |
| Stannofluorid, komb. | QA01AA51 |
| Stanozolol | QA14AA02 |
| Stanozolol | A14AA02 |
| Staphylococcus | QI04AB10 |
| Staphylococcus immunoglobulin | J06BB08 |
| Stavudin | J05AF04 |
| Stavudin | QJ05AF04 |
| Stavudin og lamivudin | QJ05AR28 |
| Stavudin og lamivudin | J05AR28 |
| Stavudin, lamivudin og nevirapin | J05AR07 |
| Stavudin, lamivudin og nevirapin | QJ05AR07 |
| Stepronin | R05CB11 |
| Stepronin | QR05CB11 |
| Sterculia | QA06AC03 |
| Sterculia | A06AC03 |
| Sterculia, kombinationer | QA06AC53 |
| Sterculia, kombinationspræparater | A06AC53 |
| Steroid antibakterika | J01XC |
| Steroid-antibakterika | QJ01XC |
| Stibophen | P02BX03 |
| Stiripentol | N03AX17 |
| Stiripentol | QN03AX17 |
| Stirofos | QP53BB04 |
| Stoffer til behandling af tuberculose | J04A |
| Stomatologica | A01A |
| Stomatologiske præparater | QA01 |
| Stomatologiske præparater | QA01A |
| Stomi-udstyr | V07AS |
| Stramonium-præparater | QR03BB03 |
| Stramonium-præparater | R03BB03 |
| Streptococcus | QI02AB18 |
| Streptoduocin | QJ01GA02 |
| Streptoduocin | J01GA02 |
| Streptograminer | J01FG |
| Streptograminer | QJ01FG |
| Streptokinase | QB01AD01 |
| Streptokinase | B01AD01 |
| Streptokinase, kombinationer | B06AA55 |
| Streptokinase, kombinationer | QB06AA55 |
| Streptokok vaccine | QI05AB01 |
| Streptokok+stafylokok+pseudomonas+corynebacterium vaccine | QI02AB16 |
| Streptomycin | QJ01GA01 |
| Streptomycin | QA07AA04 |
| Streptomycin | A07AA04 |
| Streptomycin | J01GA01 |
| Streptomycin og isoniazid | J04AM01 |
| Streptomycin og isoniazid | QJ04AM01 |
| Streptomycin, kombinationer | QA07AA54 |
| Streptomycin, kombinationer | A07AA54 |
| Streptomyciner | J01GA |
| Streptomyciner | QJ01GA |
| Streptomyciner | QJ51GA |
| Streptozocin | QL01AD04 |
| Streptozocin | L01AD04 |
| Strontium(89-sr)-chlorid | V10BX01 |
| Strontiumranelat | QM05BX03 |
| Strontiumranelat | M05BX03 |
| Strontiumranelat og colecalciferol | M05BX53 |
| Strontiumranelat og colecalciferol | QM05BX53 |
| Strophantus-glycosider | C01AC |
| Strophantus-glycosider | QC01AC |
| Styramat | M03BA04 |
| Styramat | QM03BA04 |
| Substituerede alkylaminer | R06AB |
| Substituerede alkylaminer | QR06AB |
| Substituerede ethylendiaminer | QR06AC |
| Substituerede ethylendiaminer | R06AC |
| Succinimid | G04BX10 |
| Succinimid | QG04BX10 |
| Succinimid-derivater | N03AD |
| Succinimid-derivater | QN03AD |
| Succinylsulfathiazol | A07AB04 |
| Succinylsulfathiazol | QA07AB04 |
| Sucralfat | QA02BX02 |
| Sucralfat | A02BX02 |
| Sucroferrioxyhydroxid | QV03AE05 |
| Sucroferrioxyhydroxid | V03AE05 |
| Sufentanil | QN01AH03 |
| Sufentanil | N01AH03 |
| Sugammadex | QV03AB35 |
| Sugammadex | V03AB35 |
| Sugemalimab | L01FF11 |
| Sugemalimab | QL01FF11 |
| Sulbactam | QJ01CG01 |
| Sulbactam | J01CG01 |
| Sulbenicillin | J01CA16 |
| Sulbenicillin | QJ01CA16 |
| Sulbentin | QD01AE09 |
| Sulbentin | D01AE09 |
| Sulbutiamin | A11DA02 |
| Sulbutiamin | QA11DA02 |
| Sulconazol | QD01AC09 |
| Sulconazol | D01AC09 |
| Sulcotidil | C04AX19 |
| Sulcotidil | QC04AX19 |
| Sulfacetamid | QD10AF06 |
| Sulfacetamid | QJ01EQ21 |
| Sulfacetamid | D10AF06 |
| Sulfacetamid | S01AB04 |
| Sulfacetamid | QS01AB04 |
| Sulfachlorpyridazin | QJ01EQ12 |
| Sulfachlorpyridazin og trimethoprim, incl. derivater | QJ01EW12 |
| Sulfaclozin | QP51BA03 |
| Sulfadiazin | QJ01EQ10 |
| Sulfadiazin | J01EC02 |
| Sulfadiazin og tetroxoprim | J01EE06 |
| Sulfadiazin og trimethoprim | J01EE02 |
| Sulfadiazin og trimethoprim | QJ01EW10 |
| Sulfadiazin og trimethoprim | QJ51RE01 |
| Sulfadicramid | QS01AB03 |
| Sulfadicramid | S01AB03 |
| Sulfadimethoxin | QP51BA01 |
| Sulfadimethoxin | J01ED01 |
| Sulfadimethoxin og ormetoprim | QJ01EW19 |
| Sulfadimethoxin og trimethoprim, incl. derivater | QJ01EW09 |
| Sulfadimethoxin, komb. | QJ01EQ59 |
| Sulfadimidin | QJ01EQ03 |
| Sulfadimidin | J01EB03 |
| Sulfadimidin | QP51AG01 |
| Sulfadimidin og trimethoprim | J01EE05 |
| Sulfadimidin og trimethoprim, incl. derivater | QJ01EW03 |
| Sulfadimidin, kombinationer | QP51AG51 |
| Sulfadoxin | QJ01EQ13 |
| Sulfadoxin og trimethoprim, incl. derivater | QJ01EW13 |
| Sulfafenazol | QS01AB05 |
| Sulfafenazol | S01AB05 |
| Sulfafurazol | QS01AB02 |
| Sulfafurazol | S01AB02 |
| Sulfafurazol | QJ01EQ05 |
| Sulfafurazol | J01EB05 |
| Sulfaguanidin | A07AB03 |
| Sulfaguanidin | QA07AB03 |
| Sulfaisodimidin | J01EB01 |
| Sulfalen | J01ED02 |
| Sulfalen | QJ01EQ19 |
| Sulfamazon | J01ED09 |
| Sulfamerazin | J01ED07 |
| Sulfamerazin | D06BA06 |
| Sulfamerazin | QJ01EQ17 |
| Sulfamerazin | QD06BA06 |
| Sulfamerazin og trimethoprim | QJ01EW18 |
| Sulfamerazin og trimethoprim | J01EE07 |
| Sulfamethizol | J01EB02 |
| Sulfamethizol | D06BA04 |
| Sulfamethizol | B05CA04 |
| Sulfamethizol | QJ01EQ02 |
| Sulfamethizol | QD06BA04 |
| Sulfamethizol | QB05CA04 |
| Sulfamethizol | S01AB01 |
| Sulfamethizol | QS01AB01 |
| Sulfamethomidin | J01ED03 |
| Sulfamethoxazol | J01EC01 |
| Sulfamethoxazol | QJ01EQ11 |
| Sulfamethoxazol og trimethoprim | J01EE01 |
| Sulfamethoxazol og trimethoprim, incl. derivater | QJ01EW11 |
| Sulfamethoxydiazin | J01ED04 |
| Sulfamethoxypyridazin | J01ED05 |
| Sulfamethoxypyridazin | QJ01EQ15 |
| Sulfamethoxypyridazin og trimethoprim, incl. derivater | QJ01EW15 |
| Sulfametrol og trimethoprim | J01EE03 |
| Sulfamonomethoxin | QJ01EQ18 |
| Sulfamonomethoxin og trimethoprim, inkl. derivater | QJ01EW17 |
| Sulfamoxol | J01EC03 |
| Sulfamoxol og trimethoprim | J01EE04 |
| Sulfanilamid | J01EB06 |
| Sulfanilamid | D06BA05 |
| Sulfanilamid | QJ01EQ06 |
| Sulfanilamid | QD06BA05 |
| Sulfaperin | J01ED06 |
| Sulfaphenazol | J01ED08 |
| Sulfaphenazol | QJ01EQ08 |
| Sulfapyrazol | QJ01EQ01 |
| Sulfapyridin | QJ01EQ04 |
| Sulfapyridin | J01EB04 |
| Sulfaquinoxalin | QP51BA02 |
| Sulfaquinoxalin og trimethoprim, incl. derivater | QJ01EW16 |
| Sulfaquinoxalin, kombinationer | QP51AG53 |
| Sulfasalazin | A07EC01 |
| Sulfathiazol | D06BA02 |
| Sulfathiazol | J01EB07 |
| Sulfathiazol | QJ01EQ07 |
| Sulfathiazol | QD06BA02 |
| Sulfathiourea | J01EB08 |
| Sulfatolamid | G01AE01 |
| Sulfatolamid | QG01AE01 |
| Sulfatroxazol | QJ01EQ14 |
| Sulfatroxazol og trimethoprim, incl. derivater | QJ01EW14 |
| Sulfazuinoxalin | QJ01EQ16 |
| Sulfinpyrazon | M04AB02 |
| Sulfinpyrazon | QM04AB02 |
| Sulfobromphtalein | V04CE02 |
| Sulfobromphthalein | QV04CE02 |
| Sulfonamid og trimethoprim incl. derivater i komb. | J01EE |
| Sulfonamider | G01AE |
| Sulfonamider | D06BA |
| Sulfonamider | A07AB |
| Sulfonamider | QJ01EQ |
| Sulfonamider | QG51AE |
| Sulfonamider | QG01AE |
| Sulfonamider | QD06BA |
| Sulfonamider | QA07AB |
| Sulfonamider | S01AB |
| Sulfonamider | QS01AB |
| Sulfonamider (heterocycliske) | QA10BC |
| Sulfonamider (heterocycliske) | A10BC |
| Sulfonamider i komb. | QG01AE10 |
| Sulfonamider i komb. | QG51AE10 |
| Sulfonamider i kombination | QP51AG30 |
| Sulfonamider med kort virkningstid | J01EB |
| Sulfonamider med lang virkningstid | J01ED |
| Sulfonamider med middellang virkningstid | J01EC |
| Sulfonamider og kalium i kombination | C03CB |
| Sulfonamider og kalium i kombination | C03BB |
| Sulfonamider og kalium i kombination | QC03CB |
| Sulfonamider og kalium i kombination | QC03BB |
| Sulfonamider og kortikosteroider | QG01BE |
| Sulfonamider og kortikosteroider | G01BE |
| Sulfonamider og trimethoprim | J01E |
| Sulfonamider og trimethoprim | QJ01E |
| Sulfonamider og trimethoprim | QJ51E |
| Sulfonamider og trimethoprim inkl. derivater | QJ51RE |
| Sulfonamider, komb. | QJ01EQ30 |
| Sulfonamider, komb. | QD06BA99 |
| Sulfonamider, komb. m. andre antibakterika, excl. trimethoprim | QJ01RA02 |
| Sulfonamider, komb. med andre antibakterika excl. trimethoprim | J01RA02 |
| Sulfonamider, komb. med andre stoffer | C03BK |
| Sulfonamider, komb. med andre stoffer | QG51BE |
| Sulfonamider, komb. med andre stoffer | QC03BK |
| Sulfonamider, kombinationer | QG01AE99 |
| Sulfonamider, kombinationer | QA07AB20 |
| Sulfonamider, usammensatte | QC03CA |
| Sulfonamider, usammensatte | QC03BA |
| Sulfonamider, usammensatte | C03CA |
| Sulfonamider, usammensatte | C03BA |
| Sulfonamider, usammensatte og i kombinationer | QP51AG |
| Sulfonamider, usammensatte og kombinationer mod coccidiose | QP51BA |
| Sulfonium-derivater | C02BA |
| Sulfonium-derivater | QC02BA |
| Sulfonylcarbamid | QA10BB |
| Sulfonylcarbamid | A10BB |
| Sulglicotid | A02BX08 |
| Sulglicotid | QA02BX08 |
| Sulindac | M01AB02 |
| Sulindac | QM01AB02 |
| Sulodexid | B01AB11 |
| Sulodexid | QB01AB11 |
| Sulpirid | N05AL01 |
| Sulpirid | QN05AL01 |
| Sulproston | G02AD05 |
| Sulproston | QG02AD05 |
| Sultamicillin | QJ01CR04 |
| Sultamicillin og enzym-inhibitor | J01CR04 |
| Sultiam | N03AX03 |
| Sultiam | QN03AX03 |
| Sultoprid | QN05AL02 |
| Sultoprid | N05AL02 |
| Sumatriptan | N02CC01 |
| Sumatriptan og naproxen | N02CC51 |
| Sumatriptan og naproxen | QN02CC51 |
| Sumatrptan | QN02CC01 |
| Sunitinib | L01EX01 |
| Sunitinib | QL01EX01 |
| Superparamagnetiske kontrastmidler | QV08CB |
| Superparamagnetiske kontrastmidler | V08CB |
| Suprofen | QM01AE07 |
| Suprofen | M01AE07 |
| Suraminnatrium | P01CX02 |
| Suraminnatrium | QP51AE02 |
| Surgical dressings | V20 |
| Surufatinib | QL01EX24 |
| Surufatinib | L01EX24 |
| Susoctocog alfa | B02BD14 |
| Susoctocog alfa | QB02BD14 |
| Sutimlimab | L04AJ04 |
| Sutimlimab | QL04AJ04 |
| Suvorexant | QN05CJ01 |
| Suvorexant | N05CJ01 |
| Suxamethon | M03AB01 |
| Suxamethon | QM03AB01 |
| Suxibuzon | QM01AA90 |
| Suxibuzon | QM02AA22 |
| Suxibuzon | M02AA22 |
| Svovl | D10AB02 |
| Svovl | QD10AB02 |
| Svovlforbindelser | D11AC08 |
| Svovl-forbindelser | QD11AC08 |
| Svovlhexafluorid, phospholipid mikrosfærer | QV08DA05 |
| Svovlhexafluorid, phospholipid mikrosfærer | V08DA05 |
| Svovlholdige acne-midler | QD10AB |
| Svovlholdige acne-midler | D10AB |
| Svovlholdige imidazol-derivater | H03BB |
| Svovlholdige imidazol-derivater | QH03BB |
| Svovlholdige midler | P03AA |
| Svovlholdige produkter | QP53AA |
| Sympatomimetika | QR01BA |
| Sympatomimetika | R01BA |
| Sympatomimetika anvendt som dekongestanter | QS01GA |
| Sympatomimetika anvendt som dekongestanter | S01GA |
| Sympatomimetika excl. antiglaucom-midler | S01FB |
| Sympatomimetika i glaucombehandling | QS01EA |
| Sympatomimetika til glaucombehandling | S01EA |
| Sympatomimetika, excl. glaucom-midler | QS01FB |
| Sympatomimetika, komb. | QS01FB99 |
| Sympatomimetika, komb. excl. kortikosteroider | R01AB |
| Sympatomimetika, komb. excl. kortikosteroider | QR01AB |
| Sympatomimetika, usammensatte | QR01AA |
| Sympatomimetika, usammensatte | R01AA |
| Sympatomimetika, ve-dæmpende | QG02CA |
| Sympatomimetika, vehæmmende | G02CA |
| Synt. anticholin.estere med tertiære aminogrupper | A03AA |
| Synt. antikolinergika i komb. m. psykoleptika | A03CA |
| Synt. antikolinergika i komb. med analgetika | A03DA |
| Synt. antikolinergika, estere m. tertiær aminogruppe | QA03AA |
| Synt. antikolinergika, kvarternære ammoniumforb. | QA03AB |
| Synt. antikolinergika, kvarternære ammoniumforb. | A03AB |
| Synt. antispasmodika, amider med tertiære aminer | A03AC |
| Synt. antispasmodika, amider med tertiære aminer | QA03AC |
| Syntetiske antikolinergika | QA03CA |
| Syntetiske antikolinergika i komb. med analgetika | QA03DA |
| Syntetiske østrogener, usammensatte | QG03CB |
| Syntetiske østrogener, usammensatte | G03CB |
| Syreholdige midler | QA09AB |
| Syrepræparater | A09AB |
| Syrosingopin og diuretika | C02LA09 |
| Systemiske hormonpræparater, excl. kønshormoner | H |
| Systemiske hormonpræparater, excl. kønshormoner | QH |
| Sølv | QD08AL30 |
| Sølv | D08AL30 |
| Sølvforbindelser | D08AL |
| Sølvforbindelser | S01AX02 |
| Sølv-forbindelser | QS01AX02 |
| Sølv-forbindelser | QD08AL |
| Sølvlys jordstængel | QG02CX04 |
| Sølvlys jordstængel | G02CX04 |
| Sølvnitrat | D08AL01 |
| Sølvnitrat | QD08AL01 |
| Sølvsulfadiazin | QD06BA01 |
| Sølvsulfadiazin | D06BA01 |
| Sølv-sulfadiazin, komb. | QD06BA51 |
| Sølvsulfadiazin, kombinationer | D06BA51 |
| Sårhelende midler | D03A |
| Sårhelende midler | QD03A |
